HomeComparePBE vs NNN

PBE vs NNN: Dividend Comparison 2026

PBE yields 1.11% · NNN yields 5.68%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NNN wins by $4.3K in total portfolio value· pulled ahead in Year 4
10 years
PBE
PBE
● Live price
1.11%
Share price
$78.29
Annual div
$0.87
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.3K
Annual income
$118.95
Full PBE calculator →
NNN
NNN REIT Inc.
● Live price
5.68%
Share price
$41.89
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$2,637.42
Full NNN calculator →

Portfolio growth — PBE vs NNN

📍 NNN pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPBENNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PBE + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PBE pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PBE
Annual income on $10K today (after 15% tax)
$94.10/yr
After 10yr DRIP, annual income (after tax)
$101.11/yr
NNN
Annual income on $10K today (after 15% tax)
$482.93/yr
After 10yr DRIP, annual income (after tax)
$2,241.81/yr
At 15% tax rate, NNN beats the other by $2,140.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PBE + NNN for your $10,000?

PBE: 50%NNN: 50%
100% NNN50/50100% PBE
Portfolio after 10yr
$23.4K
Annual income
$1,378.19/yr
Blended yield
5.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

PBE
No analyst data
Altman Z
3.7
Piotroski
3/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+7.3% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PBE buys
0
NNN buys
0
No recent congressional trades found for PBE or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPBENNN
Forward yield1.11%5.68%
Annual dividend / share$0.87$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$21.3K$25.6K
Annual income after 10y$118.95$2,637.42
Total dividends collected$1.2K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: PBE vs NNN ($10,000, DRIP)

YearPBE PortfolioPBE Income/yrNNN PortfolioNNN Income/yrGap
1$10,811$110.71$10,737$617.02+$74.00PBE
2$11,679$111.85$11,577$710.93+$102.00PBE
3$12,610$112.93$12,538$822.59+$72.00PBE
4← crossover$13,606$113.95$13,645$956.06$39.00NNN
5$14,674$114.92$14,925$1,116.51$251.00NNN
6$15,817$115.82$16,415$1,310.57$598.00NNN
7$17,041$116.68$18,158$1,546.77$1.1KNNN
8$18,351$117.48$20,213$1,836.20$1.9KNNN
9$19,754$118.24$22,649$2,193.37$2.9KNNN
10$21,255$118.95$25,558$2,637.42$4.3KNNN

PBE vs NNN: Complete Analysis 2026

PBEStock

The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of securities of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Full PBE Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this PBE vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PBE vs SCHDPBE vs JEPIPBE vs OPBE vs KOPBE vs MAINPBE vs ADCPBE vs EPRTPBE vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.